Truist Securities Reiterates Hold Rating on Amgen (AMGN)
Tweet Send to a Friend
Truist Securities analyst Srikripa Devarakonda reiterated a Hold rating and $298.00 price target on Amgen (NASDAQ: AMGN).The analyst commented: "MariTide ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
